Efeito da ligadura funcional na prevenção da recorrência da entorse do tornozelo numa equipa de basquetebol feminino

Introdução: O basquetebol é considerado um desporto de alto risco para a ocorrência de lesões, nomeadamente das entorses do tornozelo. Como a história de lesão anterior é um fator de risco para a ocorrência de entroses têm-se desenvolvido estratégias de prevenção para evitar as recidivas, um dos métodos possíveis é o recurso a ligaduras funcionais em “tape”. Objetivo: Neste trabalho vai-se verificar se as ligaduras funcionais em “tape” previnem a recorrência de entorse do tornozelo, numa equipa feminina de basquetebol sub-16. Métodos: A amostra é composta por 9 atletas de basquetebol sub-16 com história de entorse no tornozelo na época precedente, vão-se utilizar ligaduras funcionais no tornozelo. Resultados: A entorse teve 9 registos na época anterior. Não houve registo de qualquer lesão da tibiotársica nos treinos ou jogos, durante a aplicação das ligaduras. Conclusão: A utilização das ligaduras funcionais no grupo estudado, como método de prevenção foi eficaz, não se registando qualquer entorse no decorrer das atividades desportivas (treinos/jogos).

FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression

Background Hippocampal neurogenesis has been suggested as a downstream event of antidepressants (AD) mechanism of action and might explain the lag time between AD administration and the therapeutic effect. Despite the widespread use of AD in the context of Major Depressive Disorder (MDD) there are no reliable biomarkers of treatment response phenotypes, and a significant proportion of patients display Treatment Resistant Depression (TRD). Fas/FasL system is one of the best-known death-receptor mediated cell signaling systems and is recognized to regulate cell proliferation and tumor cell growth. Recently this pathway has been described to be involved in neurogenesis and neuroplasticity. Methods Since FAS -670A>G and FASL -844T>C functional polymorphisms never been evaluated in the context of depression and antidepressant therapy, we genotyped FAS -670A>G and FASL -844T>C in a subset of 80 MDD patients to evaluate their role in antidepressant treatment response phenotypes. Results We found that the presence of FAS -670G allele was associated with antidepressant bad prognosis (relapse or TRD: OR=6.200; 95% CI: [1.875–20.499]; p=0.001), and we observed that patients carrying this allele have a higher risk to develop TRD (OR=10.895; 95% CI: [1.362–87.135]; p=0.008).Moreover, multivariate analysis adjusted to potentials confounders showed that patients carrying G allele have higher risk of early relapse (HR=3.827; 95% CI: [1.072–13.659]; p=0.039). FAS mRNA levels were down-regulated among G carriers, whose genotypes were more common in TRD patients. No association was found between FASL-844T>C genetic polymorphism and any treatment phenotypes. Limitations Small sample size. Patients used antidepressants with different mechanisms of action. Conclusion To the best of our knowledge this is the first study to evaluate the role of FAS functional polymorphism in the outcome of antidepressant therapy. This preliminary report associates FAS -670A>G genetic polymorphism with Treatment Resistant Depression and with time to relapse. The current results may possibly be given to the recent recognized role of Fas in neurogenesis and/or neuroplasticity.